These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1031 related items for PubMed ID: 14661123

  • 1. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C, Steder-Neukamm U, Glas K, Sander S, Ring C, Klaus J, Reinshagen M.
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [Abstract] [Full Text] [Related]

  • 2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M.
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [Abstract] [Full Text] [Related]

  • 3. [Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients].
    Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A.
    Gastroenterol Clin Biol; 2003 Oct; 27(10):901-7. PubMed ID: 14631305
    [Abstract] [Full Text] [Related]

  • 4. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA, Hamdy NA.
    Scand J Gastroenterol Suppl; 2006 Oct; (243):59-64. PubMed ID: 16782623
    [Abstract] [Full Text] [Related]

  • 5. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
    Ben Hamida KS, Serghini M, Ksontini I, Kedadi H, Ben Yaghléne L, Bougassas W, Dougui MH.
    Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P.
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [Abstract] [Full Text] [Related]

  • 7. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F, Rashidi M, Hashemi S, Kangavari M, Bahari A, Daryani NE, Emam MM, Naderi N, Shalmani HM, Farnood A, Zali M.
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M, Tron I, Alexandre JL, Cruchant E, Dabadie A, Chaperon J, Robaszkiewicz M, Bretagne JF.
    Gastroenterol Clin Biol; 1997 Dec; 21(6-7):483-90. PubMed ID: 9295976
    [Abstract] [Full Text] [Related]

  • 10. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV, EC-IBD Study Group.
    Digestion; 2007 Dec; 75(2-3):113-21. PubMed ID: 17598963
    [Abstract] [Full Text] [Related]

  • 11. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F.
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [Abstract] [Full Text] [Related]

  • 12. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M, Zénut M, Aublet-Cuvelier B, Larpent JL, Fabre P, Abergel A, Dapoigny M, Bommelaer G.
    Gastroenterol Clin Biol; 1997 Feb; 21(6-7):491-6. PubMed ID: 9295977
    [Abstract] [Full Text] [Related]

  • 13. Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.
    Noble CL, McCullough J, Ho W, Lees CW, Nimmo E, Drummond H, Bear S, Hannan J, Millar C, Ralston SH, Satsangi J.
    Aliment Pharmacol Ther; 2008 Apr 01; 27(7):588-96. PubMed ID: 18194505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.
    Lee N, Fowler E, Mason S, Lincoln D, Taaffe DR, Radford-Smith G.
    J Gastroenterol Hepatol; 2007 Jun 01; 22(6):913-9. PubMed ID: 17565648
    [Abstract] [Full Text] [Related]

  • 16. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Jun 01; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA, De Jesús R, Pérez CM, Iñesta M, Torres D, Morell C, Just E.
    P R Health Sci J; 2003 Sep 01; 22(3):253-8. PubMed ID: 14619451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN, Leslie WD.
    Aliment Pharmacol Ther; 2004 May 01; 19(9):941-52. PubMed ID: 15113361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.